Trimegestone

DB13129InvestigationalSmall molecule

Trimegestone has been used in trials studying the treatment of Postmenopause.

Chemical structure of Trimegestone
Mechanism
Curator reviewed
Formula / weight
C22H30O3 · 342.479 g/mol (avg)
Code names
RU-27987

Resolves to

Compound
UNII4658K0H08WCAS74513-62-5ChEMBLCHEMBL2104765ChEBI136027PubChem68926
Clinical / RWD
ATCG03FA16ATCG03FB11
Structure
InChIKeyJUNDJWOLDSCTFK-MTZCLOFQSA-NSMILESC[C@H](O)C(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C
Targets
P06401PGR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2ATC codesIncluding every combination product, plus 8 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Trimegestone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In